Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    Menu

    APG-1387

    DEVELOPMENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Apg-1387, 1570231-89-8, E53vn70k2x, Apg1387, (s,5s,5's,8s,8's,10ar,10a'r)-3,3'-(1,3-phenylenedisulfonyl)bis(n-benzhydryl-5-((s)-2-(methylamino)propanamido)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide), Unii-e53vn70k2x
    Molecular Formula
    C60H72N10O10S2
    Molecular Weight
    1157.4  g/mol
    InChI Key
    AKLBERUGKZNEJY-RTEPGWBGSA-N
    FDA UNII
    E53VN70K2X
    IAP Inhibitor APG-1387 is a small molecule, second mitochondria-derived activator of caspases (SMAC)-mimetic targeting inhibitor of apoptosis proteins (IAPs) with potential apoptosis-inducing and antineoplastic activities. Upon administration, IAP inhibitor APG-1387 selectively binds to and inhibits the activity of IAPs including X chromosome-linked IAP (XIAP) and cellular IAPs 1 (c-IAP1) and 2 (c-IAP2). This may restore and promote the induction of apoptosis through apoptotic signaling pathways and enhance proteasomal degradation of IAPs. Additionally, APG-1387 may work synergistically with cytotoxic drugs to overcome tumor cell resistance to apoptosis. IAPs are overexpressed by many cancer cell types, suppressing apoptosis by binding and inhibiting active caspases-3, -7 and -9 via their BIR (baculoviral lAP repeat) domains.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (5S,8S,10aR)-3-[3-[[(5S,8S,10aR)-8-(benzhydrylcarbamoyl)-5-[[(2S)-2-(methylamino)propanoyl]amino]-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocin-3-yl]sulfonyl]phenyl]sulfonyl-N-benzhydryl-5-[[(2S)-2-(methylamino)propanoyl]amino]-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide
    2.1.2 InChI
    InChI=1S/C60H72N10O10S2/c1-39(61-3)55(71)63-49-37-67(34-32-45-28-30-51(69(45)59(49)75)57(73)65-53(41-18-9-5-10-19-41)42-20-11-6-12-21-42)81(77,78)47-26-17-27-48(36-47)82(79,80)68-35-33-46-29-31-52(70(46)60(76)50(38-68)64-56(72)40(2)62-4)58(74)66-54(43-22-13-7-14-23-43)44-24-15-8-16-25-44/h5-27,36,39-40,45-46,49-54,61-62H,28-35,37-38H2,1-4H3,(H,63,71)(H,64,72)(H,65,73)(H,66,74)/t39-,40-,45+,46+,49-,50-,51-,52-/m0/s1
    2.1.3 InChI Key
    AKLBERUGKZNEJY-RTEPGWBGSA-N
    2.1.4 Canonical SMILES
    CC(C(=O)NC1CN(CCC2CCC(N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)S(=O)(=O)C5=CC(=CC=C5)S(=O)(=O)N6CCC7CCC(N7C(=O)C(C6)NC(=O)C(C)NC)C(=O)NC(C8=CC=CC=C8)C9=CC=CC=C9)NC
    2.1.5 Isomeric SMILES
    C[C@@H](C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)S(=O)(=O)C5=CC(=CC=C5)S(=O)(=O)N6CC[C@H]7CC[C@H](N7C(=O)[C@H](C6)NC(=O)[C@H](C)NC)C(=O)NC(C8=CC=CC=C8)C9=CC=CC=C9)NC
    2.2 Other Identifiers
    2.2.1 UNII
    E53VN70K2X
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Apg-1387

    2.3.2 Depositor-Supplied Synonyms

    1. Apg-1387

    2. 1570231-89-8

    3. E53vn70k2x

    4. Apg1387

    5. (s,5s,5's,8s,8's,10ar,10a'r)-3,3'-(1,3-phenylenedisulfonyl)bis(n-benzhydryl-5-((s)-2-(methylamino)propanamido)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide)

    6. Unii-e53vn70k2x

    7. Schembl15490706

    8. Apg-1387 [who-dd]

    9. A][1,5]diazocine-8-carboxamide)

    10. Ex-a5180

    11. Apg-1387 (smac Mimetic)

    12. Nsc834197

    13. Nsc-834197

    14. Sm-1387

    15. Hy-125593

    16. Cs-0092417

    17. Phenylenedisulfonyl)bis(n-benzhydryl-5-((s)-2-

    18. (methylamino)propanamido)-6-oxodecahydropyrrolo[1,2-

    19. (5s,5's,8s,8's,10ar,10a'r)-3,3'-(1,3-

    2.4 Create Date
    2014-03-31
    3 Chemical and Physical Properties
    Molecular Weight 1157.4 g/mol
    Molecular Formula C60H72N10O10S2
    XLogP34.5
    Hydrogen Bond Donor Count6
    Hydrogen Bond Acceptor Count14
    Rotatable Bond Count18
    Exact Mass1156.48743088 g/mol
    Monoisotopic Mass1156.48743088 g/mol
    Topological Polar Surface Area273 Ų
    Heavy Atom Count82
    Formal Charge0
    Complexity2240
    Isotope Atom Count0
    Defined Atom Stereocenter Count8
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.